Cytokine effects on the basal ganglia and dopamine function: The subcortical source of inflammatory malaise

被引:274
作者
Felger, Jennifer C.
Miller, Andrew H. [1 ]
机构
[1] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA
基金
美国国家卫生研究院;
关键词
Inflammatory cytokines; Interferon-alpha; Inflammation; Dopamine; Tetrahydrobiopterin; Kynurenine; Oxidative stress; Basal ganglia; Fatigue; Depression; BLOOD-BRAIN-BARRIER; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; MAJOR DEPRESSIVE DISORDER; POSITRON-EMISSION-TOMOGRAPHY; SYNAPTOSOMAL GLUTAMATE RELEASE; RANDOMIZED CLINICAL-TRIAL; INDUCED SICKNESS BEHAVIOR; ACTIVATED PROTEIN-KINASE; INTERFERON-ALPHA THERAPY;
D O I
10.1016/j.yfrne.2012.09.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Data suggest that cytokines released during the inflammatory response target subcortical structures including the basal ganglia as well as dopamine function to acutely induce behavioral changes that support fighting infection and wound healing. However, chronic inflammation and exposure to inflammatory cytokines appears to lead to persisting alterations in the basal ganglia and dopamine function reflected by anhedonia, fatigue, and psychomotor slowing. Moreover, reduced neural responses to hedonic reward, decreased dopamine metabolites in the cerebrospinal fluid and increased presynaptic dopamine uptake and decreased turnover have been described. This multiplicity of changes in the basal ganglia and dopamine function suggest fundamental effects of inflammatory cytokines on dopamine synthesis, packaging, release and/or reuptake, which may sabotage and circumvent the efficacy of current treatment approaches. Thus, examination of the mechanisms by which cytokines alter the basal ganglia and dopamine function will yield novel insights into the treatment of cytokine-induced behavioral changes and inflammatory malaise. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:315 / 327
页数:13
相关论文
共 229 条
[1]   Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression [J].
aan het Rot, Marije ;
Collins, Katherine A. ;
Murrough, James W. ;
Perez, Andrew M. ;
Reich, David L. ;
Charney, Dennis S. ;
Mathew, Sanjay J. .
BIOLOGICAL PSYCHIATRY, 2010, 67 (02) :139-145
[2]   Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma [J].
Ahles, TA ;
Saykin, AJ ;
Furstenberg, CT ;
Cole, B ;
Mott, LA ;
Skalla, K ;
Whedon, MB ;
Bivens, S ;
Mitchell, T ;
Greenberg, ER ;
Silberfarb, PM .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) :485-493
[3]   EXPRESSION OF MRP14, 27E10, INTERFERON-ALPHA AND LEUKOCYTE COMMON ANTIGEN BY REACTIVE MICROGLIA IN POSTMORTEM HUMAN BRAIN-TISSUE [J].
AKIYAMA, H ;
IKEDA, K ;
KATOH, M ;
MCGEER, EG ;
MCGEER, PL .
JOURNAL OF NEUROIMMUNOLOGY, 1994, 50 (02) :195-201
[4]   Cytokines, stress and depressive illness: brain-immune interactions [J].
Anisman, H ;
Merali, Z .
ANNALS OF MEDICINE, 2003, 35 (01) :2-11
[5]  
Anisman H, 1999, ADV EXP MED BIOL, V461, P199
[6]   Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders [J].
Anisman, Hymie ;
Merali, Zul ;
Hayley, Shawn .
PROGRESS IN NEUROBIOLOGY, 2008, 85 (01) :1-74
[7]  
[Anonymous], MOL PSYCHIAT
[8]   Passage of cytokines across the blood-brain barrier [J].
Banks, WA ;
Kastin, AJ ;
Broadwell, RD .
NEUROIMMUNOMODULATION, 1995, 2 (04) :241-248
[9]   Entry of blood-borne cytokines into the central nervous system: Effects on cognitive processes [J].
Banks, WA ;
Farr, SA ;
Morley, JE .
NEUROIMMUNOMODULATION, 2002, 10 (06) :319-327
[10]   The blood-brain barrier and immune function and dysfunction [J].
Banks, William A. ;
Erickson, Michelle A. .
NEUROBIOLOGY OF DISEASE, 2010, 37 (01) :26-32